Introduction {#s1}
============

During brain development, neural stem cells (NSCs) generate large numbers of highly diverse neuronal and glial cells in chronological order ([@bib16]; [@bib21]; [@bib24]; [@bib27]). Through a phenomenon known as temporal patterning, NSCs acquire properties that change the fate of their progeny over time ([@bib39]; [@bib52]; [@bib59]). Importantly, temporal patterning of NSCs is an evolutionary conserved process and has been observed across species ranging from insects to mammals ([@bib3]; [@bib48]; [@bib69]). During mammalian brain development, neural progenitors in the central nervous system (CNS) undergo temporal patterning by relying on both extrinsic as well as progenitor-intrinsic cues. Wnt7, for example, is an extracellular ligand required for the switch from early to late neurogenesis in cortical progenitors ([@bib73]), Ikaros (the ortholog of the Drosophila Hunchback), in contrast, is an intrinsic factor specifying early-born neuronal fates ([@bib52]). Like Ikaros, intrinsic temporal identity factors in vertebrates are often homologous to factors described in *Drosophila* ([@bib56]; [@bib63]; [@bib68]). How these factors are involved in neuronal fate specification and how they are regulated remain unknown.

*Drosophila* has been crucial to understanding stem cell biological mechanisms and in particular distinct temporal patterning processes ([@bib29]). During embryonic neurogenesis, *Drosophila* NSCs, called Neuroblasts (NBs), undergo temporal patterning through a cascade of transcription factors ([@bib33]). During larval neurogenesis, NB temporal patterning relies on opposing gradients of two RNA-binding proteins ([@bib46]; [@bib68]). Temporal patterning is also seen in intermediate neural progenitors (INPs), the transit-amplifying progeny of a discrete subset of larval NBs called type II NBs ([@bib8]). Once they arise from an asymmetric division of a type II NB, newborn INPs undergo several maturation steps before they resume proliferation: they first turn on earmuff (erm), and Asense (ase), and finally Deadpan (Dpn) expression to become mature INPs (mINP) ([@bib9]; [@bib13]; [@bib14]; [@bib35]; [@bib72]). Then mINPs divide 3--6 times asymmetrically to generate ganglion mother cells (GMCs), which in turn divide to generate a pair of neurons or glia. Analogous to embryonic NBs ([@bib33]), recent reports suggest that a transcription factor cascade regulates temporal patterning of INPs ([@bib8]). Indeed, the sequential expression of Dichaete (D), Grainyhead (Grh) and Eyeless (Ey) is required to generate different neurons: D^+^ INPs produce Brain-specific homeobox (Bsh)^+^ neurons, while Ey^+ ^INPs produce Toy^+^ neurons ([@bib8]).

The three temporal identity factors are regulated through various regulatory interactions ([@bib8]; [@bib17]): D is necessary, but not sufficient, for activating Grh. Grh instead is required for repression of D and activation of Ey ([@bib8]). Therefore, INP temporal patterning is thought to be regulated by a 'feedforward activation and feedback repression' mechanism ([Figure 1A](#fig1){ref-type="fig"}). Intriguingly however, INP temporal patterning also critically requires the SWI/SNF chromatin remodeling complex subunit Osa ([@bib20]). Although Osa is not considered a specific temporal identity factor, it is required to initiate temporal patterning by activating the initial factor D. While the Osa target gene hamlet is required for the Grh-to-Ey transition ([@bib20]), regulation of the first transition is less well understood. This result suggests that in addition to feedforward activation and feedback repression, temporal switch genes are required to ensure correct INP temporal patterning. Nevertheless, D and ham double knock down (k.d.) phenotypes do not recapitulate the complete loss of temporal patterning initiation observed in Osa-depleted type II NB lineages, suggesting the contribution of additional unidentified factors.

Here, we describe a FACS-based method to isolate INPs from three different temporal identities. By comparing the transcriptomic profiles of each set of INPs, we identify odd-paired (opa), a transcription factor whose expression is enabled by direct binding of Osa to its TSS, as a regulator of temporal patterning and repressor of D. Though Osa enables both D and Opa expression, Opa's slower activation kinetics allow D to function in a short time window before being repressed by Opa. This mode of action resembles an incoherent feedforward-loop (FFL) motif, where an upstream gene directly activates the target gene, meanwhile indirectly repressing it by activating its repressor ([@bib2]; [@bib51]). Thus, we uncover a novel mechanism controlling temporal patterning during neurogenesis.

Results {#s2}
=======

Transcriptome analysis of distinct INP temporal states {#s2-1}
------------------------------------------------------

To obtain a comprehensive list of temporally regulated genes in INPs, we used FACS to purify INPs at each of their three temporal states: D^+^, Grh^+^ and Ey^+^ ([Figure 1B](#fig1){ref-type="fig"}). For this, we generated fly lines expressing tdTomato under an INP specific promoter (erm-Gal4 \>CD8::tdTomato) and expressing GFP-fusions of one of the temporal identity factors (D-GFP, Grh-GFP and Ey-GFP, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Although D-GFP flies were generated with CRISPR/Cas9 method to knock-in GFP into the endogenous locus, Grh-GFP and Ey-GFP flies were generated as BAC clones insertions ([@bib67]). To test if extra copies from BAC clones cause overexpression effects, numbers of each temporal state were quantified in control versus GFP-tagged brains ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). After dissection and dissociation of third instar larval brains, GFP-positive INP populations (D-GFP^+^, Grh-GFP^+^ and Ey-GFP^+^) were identified ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}) as the largest cells with highest GFP and tdTomato expression ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Using immunofluorescence (IF), these cells were verified to be mature INPs ([Figure 1---figure supplement 1C-D](#fig1s1){ref-type="fig"}). All sorted cells within the INP populations expressed Dpn, indicating a 100% mature INP identity, while unsorted cells showed a mixture of Dpn^+^ and Dpn^-^ cells ([Figure 1---figure supplement 1C-D](#fig1s1){ref-type="fig"}). We validated the temporal identity of the progenitors by performing IF for their respective temporal identity markers ([Figure 1C--F](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Importantly, each GFP^+^ sorted INP population was 100% positive for its respective temporal marker ([Figure 1F](#fig1){ref-type="fig"}). In contrast, the unsorted cells consisted of mixed cell populations containing various temporal identities ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). Lastly, we tested for the presence of sorted cells expressing markers of two temporal identities, which reflects transition states of INP temporal patterning as occurs in vivo. Analyzing Grh IF on D-GFP^+^ and Ey-GFP^+^ sorted cells, and Ey IF on Grh-GFP^+^ sorted cells revealed that sorted populations contained only 4--6% of such double-positive cells ([Figure 1C--F](#fig1){ref-type="fig"}, and [Figure 1---figure supplement 2A-C](#fig1s2){ref-type="fig"}), suggesting we can isolate almost pure populations of different temporal states. Collectively, we established the genetic tools and methodology to precisely sort INPs into separate populations according to their three distinct temporal states.

![Transcriptomic analysis of temporally staged-INPs.\
(**A**) Cartoon depicting a typical type II neuroblast of larval *Drosophila* brain; NB and imINPs (empty circles) are followed by mINPs and neurons, GMCs omitted for simplicity. INPs are temporally patterned with Dichaete (blue), Grainyhead (red), and Eyeless (orange), and neurons are Bsh (green) or Toy (brown) positive. Summary of the regulation of temporal identity factors, and their progeny. (**B**) Cartoon illustrating the strategy used to isolate temporally-staged INPs. (**C--E**) D-, Grh and Ey-GFP FACS-sorted cells are stained for D and Grh (**C**), Grh or Ey (**D--E**), GFP-tagging temporal identity factors (in green, D or, Grh or Ey), tdTomato tagging the membrane of INPs (magenta), antibody staining (gray) scale bar 10 μm, (induced with ermGal4, marked with membrane bound tdTomato). (**F**) Graphs showing the percentage of temporal identity positive cells in D-, Grh- or Ey-GFP FACS sorted cells. n numbers are depicted on the graphs. (**G**) Hierarchical clustering analysis of gene log2fc between three different temporally-staged INP populations. (**H**) qPCR analysis of opa and ham expression levels in FACS-sorted D^+^, Grh^+^ and Ey^+^ INPs. Data are mean ± SD, n = 3, genes were normalized to Act5c, and then the average expression levels, Delta-Delta Ct method is used. (**I**) Graph showing the rpm levels of opa and ham between different INP temporal stages.\
10.7554/eLife.46566.006Figure 1---source data 1.Quantification of temporally FACS-sorted INPs for temporal markers ([Figure 1F](#fig1){ref-type="fig"}).\
10.7554/eLife.46566.007Figure 1---source data 2.qPCR data ([Figure 1H](#fig1){ref-type="fig"}).\
10.7554/eLife.46566.008Figure 1---source data 3.Rpm levels of opa and ham genes in three different temporal states of INPs ([Figure 1I](#fig1){ref-type="fig"}).](elife-46566-fig1){#fig1}

Since our stringent FACS sorting conditions led to low RNA yields, we generated cDNA libraries using DigiTag ([@bib41]; [@bib75]). With this RNA sequencing strategy, we found 458 genes expressed differently between D^+^ and Grh^+^ INPs, and 466 genes between Grh^+^ and Ey^+^ INPs (FDR 0.05, log2foldchange \> 1, and Rpm (reads per million mapped reads)\>10 in one of three samples/D^+^, Grh^+^ or Ey^+^ INPs). Hierarchical clustering identified genes specifically expressed in certain temporal states, and therefore potentially involved in temporal patterning ([Figure 1G](#fig1){ref-type="fig"}). First, we confirmed the quality of our dataset by examining the transcriptional changes of temporal identity genes with quantitative PCR (qPCR) ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}). As expected, each temporal state had high expression levels of their own temporal identity genes. Second, we confirmed the expression of known temporal identity genes ([Figure 1---figure supplement 1F](#fig1s1){ref-type="fig"}). FACS-purified Grh^+^ INPs expressed high levels of Ey mRNA. However, immunofluorescent analysis showed that Grh^+^ INPs expressed only low levels of Ey protein, suggesting that post-transcriptional modifications regulate the Grh-to-Ey transition ([Figure 1C--F](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1F](#fig1s1){ref-type="fig"}). Third, we performed GO-term analysis on the identified gene clusters. Genes upregulated in D^+^ INPs showed enrichment for mitochondrial translation, cellular nitrogen compound metabolic process and gene expression ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). Genes upregulated in Grh +INPs were enriched for protein binding and system development ([Figure 1---figure supplement 2E](#fig1s2){ref-type="fig"}). Finally, genes upregulated in Ey +INPs were enriched for neurogenesis and sequence-specific DNA binding ([Figure 1---figure supplement 2F](#fig1s2){ref-type="fig"}). Interestingly, we observed that the glial identity-promoting factor glial cell missing (gcm) and cell cycle inhibitor dacapo (dap) were upregulated in Ey^+^ INPs ([Figure 1G---figure supplement 1F](#fig1s1){ref-type="fig"}). These observations support previous findings indicating that INPs begin producing glia cells instead of neurons during their later cell divisions, and that Ey is required for cell cycle exit ([@bib6]; [@bib8]; [@bib64]; [@bib71]). To identify genes that regulate transitions of temporal patterning, we focused on genes with a dynamic expression pattern between INP populations. To this end, we focused on genes with a log2foldchange \> 1 in either the D-to-Grh or Grh-to-Ey transition. From this list, we excluded genes with a log2foldchange \< 0.5 in the remaining transition. We applied a cut-off of Rpm (reads per million mapped reads)\>50 in one of the three temporal identity states due to the fact that all the other temporal identity factors, along with osa and ham, had high expression levels. With these criteria, we identified 71 genes ([Supplementary file 1](#supp1){ref-type="supplementary-material"} and [Supplementary file 2](#supp2){ref-type="supplementary-material"}), 49 of which displayed an expression pattern of high in D + INPs, low in Grh +INPs, and finally higher in Ey +INPs. Among these genes, odd-paired (opa) was ranked as the 5^th^ hit that is most downregulated in Grh^+^ INPs ([Figure 1G--I](#fig1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Since Osa binds to the TSS of opa in order to prime its expression ([@bib20]), we investigated in detail the potential role of Opa in regulating INP temporal patterning.

Odd-paired (opa) is required for the progression of INP temporal patterning {#s2-2}
---------------------------------------------------------------------------

Opa is a transcription factor containing five zinc finger domains and is essential for para-segmental subdivision of *Drosophila* embryos ([@bib10]; [@bib55]). During development, Opa ensures the timely activation of the transcription factors engrailed and wingless ([@bib10]). To test if opa regulates INP temporal patterning, we depleted opa using RNAi expressed specifically in INPs with ermGal4. Opa knockdown slightly increased the total number of INPs (Dpn^+^ cells), but drastically increased the number of D^+^ INPs while decreasing the number of both Grh^+^ and Ey^+^ INPs ([Figure 2A--D](#fig2){ref-type="fig"}). We confirmed this result by performing mosaic analysis with a repressible cell marker (MARCM) to create mosaic opa (-/-) mutant or control opa (+/+) GFP^+^ cell clones ([@bib43]). Control clones were indistinguishable from WT, whereas opa mutant clones contained predominantly D^+^ INPs, at the expense of the other two temporal states ([Figure 2E--F](#fig2){ref-type="fig"}). The RNAi and mosaic mutant analysis both indicate that loss of Opa causes a shift in INP temporal state identity such that the early generated D^+^ INPs are increased while the later generated Grh^+^ and Ey^+^ INPs are decreased. These results suggest that opa is regulating the D-to-Grh transition by either repressing D or activating Grh. Since it has been previously shown that Grh is not sufficient for D repression ([@bib8]), we tested whether the main role of opa is to repress D. For this, we depleted opa in DM1 lineages, which undergo temporal patterning by expressing only D and then Ey ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Opa knock-down in DM1 lineages caused a significant increase in the number of D^+^ INPs at the expense of Ey^+^ INPs, suggesting that opa is required for D repression ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

![Opa is required for the progression of temporal patterning of INPs.\
(**A**) Close-up images of larval brains expressing RNAi against opa in INPs, stained for Dpn and D (induced with ermGal4, marked with membrane bound GFP). Lineages are outlined with yellow dashed line. (**B**) Close-up images of larval brains expressing RNAi against opa in INPs, stained for Dpn and Grh (induced with ermGal4, marked with membrane bound GFP). Lineages are outlined with yellow dashed line. (**C**) Close-up images of larval brains expressing RNAi against opa in INPs, stained for Dpn and Ey (induced with ermGal4, marked with membrane bound GFP). Lineages are outlined with yellow dashed line. (**D**) Quantification of INP numbers in different temporal stages identified by antibody staining of Dpn^+^, D^+^ cells, Dpn^+^, Grh^+^ cells, and Dpn^+^, Ey^+^ cells in control and opa knock-down brains, n = 10, total INP numbers in control were normalized to 100%. Data represent mean ± SD, \*\*\*p\<=0.001, Student's t-test (D^+^ INPs control 12.44 ± 1.42 \[n = 10\], opa RNAi 34.66 ± 1.02 \[n = 12\], p\<0.001; Grh^+^ INPs control 8.5 ± 1.32 \[n = 10\], opa RNAi 0.5 ± 0.65 \[n = 12\], p\<0.001; Ey^+^ INPs control 13.2 ± 0.98 \[n = 10\], opa RNAi 0.2 ± 0.4 \[n = 10\], p\<0.001). (**E**) Control and opa mutant MARCM clones marked by membrane-bound GFP, stained for Dpn, Grh and D after 120 hr of induction. Control clone has D^+^, Dpn^+^ INPs followed by Grh^+^ INPs while opa mutant clone has increased number of D^+^ INPs and decreased number of Grh^+^ INPs. (**F**) Control and opa mutant MARCM clones marked by membrane-bound GFP, stained for Dpn, D and Ey after 120 hr of induction. Opa mutant clone has higher number of D^+^ INPs and lower number of Ey^+^ INPs. Scale bar 10 μm in all images.\
10.7554/eLife.46566.016Figure 2---source data 1.Quantification of number of INPs in three different temporal identities between control versus opa-depleted brains with INP-specific driver ([Figure 2D](#fig2){ref-type="fig"}).](elife-46566-fig2){#fig2}

Finally, we tested if opa regulates processes upstream of temporal patterning during the stages of initial INP maturation with a type II-specific driver line. When expressing opa RNAi specifically in type II NBs, we observed no effect on INP maturation ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}) as observed with sequential activation of Ase and Dpn, but immunofluorescent analysis of INPs for D, Grh and Ey expression showed the same phenotype as INPs depleted for opa ([Figure 2---figure supplement 2B-D](#fig2s2){ref-type="fig"}). Collectively, these data suggest that opa inhibits D expression. Furthermore, similar to hamlet, Opa appears to act as a temporal identity switch gene, controlling the transition from a D^+^ to a Grh^+^ state. To test if opa knock-down impairs INP asymmetric cell division leading to the disruption in temporal patterning, we analyzed the expression of Mira, a known scaffolding protein that localizes asymmetrically during cell division, and aPKC, which localizes to apical cortex ([Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}). Opa-depleted INPs can asymmetrically segregate Mira and aPKC, which suggests that asymmetric division is normal. Thus, opa is indeed a temporal switch factor required for the D-to-Grh state.

Opa regulates the transition from early to late born neurons and is required for motor function {#s2-3}
-----------------------------------------------------------------------------------------------

INP temporal patterning results in the production of different neuronal subtypes at distinct periods of neurogenesis. For instance, 'young', D^+^ INPs produce Brain-specific homeobox (Bsh)^+^ neurons and 'old', Ey^+^ INPs produce Toy^+^ neurons ([@bib8]). Since the progression of INP temporal identity is disrupted in opa-depleted INPs, we tested whether this disrupted identity affects the production of different types of neurons. INP-driven opa RNAi displayed a significant increase in Bsh^+^ neurons, at the expense of Toy^+^ neurons ([Figure 3A--C](#fig3){ref-type="fig"}). In addition, opa-depleted MARCM clones also contained increased numbers of Bsh^+ ^neurons compared to wild-type counterparts ([Figure 3D](#fig3){ref-type="fig"}). This result confirms that shifting the INP identity toward a D^+^ identity leads to a concomitant increase in the Bsh^+^ neurons produced by D^+^ INPs. Thus, altering the temporal identity progression of neural progenitors can alter the proportions of neuronal subtypes in the brain.

![opa is an important factor for the generation of both early and late-born INP progeny and contributes to adult brain central complex.\
(**A--B**) Close-up images of larval brains expressing RNAi against opa in INPs, immunofluorescence for Bsh (**A**), and Toy (**B**) neuronal markers, scale bar 10 μm, lineages are outlined with yellow dashed line (induced with ermGal4, marked with membrane bound GFP). (**C**) Quantification of Bsh^+^ and Toy^+^ neurons in control and opa knock-down brains, n = 11, total Bsh^+^ or Toy^+^ neuron numbers in control were normalized to 100%. Data represent mean ± SD, \*\*\*p\<=0.001, Student's t-test. (**D**) Control and opa mutant MARCM clone marked by membrane-bound GFP, stained with Mira, Ase, and Bsh antibodies after 120 hr of induction. The clones are marked with yellow dashed line, scale bar 10 μm. (**E**) Close-up images of adult central complex, composed of fan-shaped body (FB), noduli (NO), ellipsoid body (EB), and protocerebral bridge (PB) of control and opa knock-down brains, stained with Bruchpilot antibody (gray) (induced with ermGal4) scale bar 50 μm. (**F**) Negative geotaxis assay with control and opa RNAi expressing flies (induced with ermGal4, marked with membrane bound GFP). For each genotype n = 10 replicates, each consisting of 10 adult female or male adults. Data are mean ± SD, \*\*\*p\<0.001, Student's t-test.\
10.7554/eLife.46566.020Figure 3---source data 1.Quantification of Bsh^+^ or Toy^+^ neuron numbers in control versus opa-depleted brains with INP-specific driver ([Figure 3C](#fig3){ref-type="fig"}).\
10.7554/eLife.46566.021Figure 3---source data 2.Quantification of the percentage pass rate of flies with control versus opa-depleted brains ([Figure 3F](#fig3){ref-type="fig"}).](elife-46566-fig3){#fig3}

We next investigated whether altering the proportions of neuronal subtypes leads to a defect on brain morphology and function. The adult central complex (CCX) brain region relies on type II NB neurogenesis ([@bib7]; [@bib34]). Opa-depletion in INPs caused major alterations in the gross morphology of the adult CCX. The fan-shaped body (FB) was enlarged, the noduli (NO) and ellipsoid body (EB) only partially formed, and the protocerebral bridge (PB) appeared fragmented ([Figure 3E](#fig3){ref-type="fig"}). Since the CCX is required for adult motor functions ([@bib15]; [@bib76]), we tested whether altered CCX morphology affected motor behavior. Compared to control flies, INP-driven *opa* RNAi caused impaired negative geotaxis performance ([Figure 3F](#fig3){ref-type="fig"}). Thus, opa is a temporal switch gene required for neuronal subtype specification, which is required for the correct assembly and function of the adult central complex. Thus, the temporal identity specification of neural progenitors is crucial for proper neural cell complexity, and brain function.

Dichaete and Opa are sequentially expressed in INPs {#s2-4}
---------------------------------------------------

If opa is required for the D-to-grh transition, what is the molecular mechanism of this transitional regulation? To answer this question, we first confirmed that opa is indeed a target of Osa in type II NB lineages by analyzing opa protein expression within the NB lineage, and whether this expression is regulated by Osa. We generated healthy, homozygous, endogenously C-terminally tagged opa::V5 knock-in flies ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Through immunofluorescent analysis of V5 tag expression, we observed that Opa is expressed throughout the type II lineage in INPs (marked with Dpn and Ase) and, GMCs (Pros^+^ cells) and neurons, but not in NBs (Dpn^+^) or immature INPs (Dpn^-^/Ase^-^ or Dpn^-^/Ase^+^ cells) ([Figure 4---figure supplement 1B-D](#fig4s1){ref-type="fig"}). Opa is also expressed in the DM1 lineage, even though DM1 lineages display a temporal patterning lacking Grh expression ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}). To check the specificity of the opa-V5 line, we depleted opa specifically in type II lineages using RNAi. As expected, opa-V5 expression decreased with opa-RNAi ([Figure 4---figure supplement 1E-F](#fig4s1){ref-type="fig"}). The proper expression of opa is dependent on Osa, since Osa-knockdown in type II NBs resulted in a loss of Opa ([Figure 4---figure supplement 2A and B](#fig4s2){ref-type="fig"}).

Since both D and opa are direct Osa targets, we next compared the expression pattern of D and opa ([Figure 4A](#fig4){ref-type="fig"}). Without exception, D^+^/opa^-^ INPs appeared before D^+^/opa^+^ cells in the lineage ([Figure 4A](#fig4){ref-type="fig"}). However, in later temporal states, all Grh^+^ and Ey^+^ INPs expressed opa ([Figure 4B](#fig4){ref-type="fig"}, and [Figure 4---figure supplement 3A](#fig4s3){ref-type="fig"}). Our transcriptome data suggest that opa expression fluctuates throughout the three different INP populations. To confirm this hypothesis, we calculated the intensity of the opa-V5 signal among these three populations ([Figure 4C--D](#fig4){ref-type="fig"}, and [Figure 4---figure supplement 3B](#fig4s3){ref-type="fig"}). Indeed, we found that D^+^ INPs express the highest opa protein levels ([Figure 4C](#fig4){ref-type="fig"}), while Grh^+^ INPs express the lowest ([Figure 4D](#fig4){ref-type="fig"} and [Figure 4---figure supplement 3B](#fig4s3){ref-type="fig"}). Since D expression precedes opa expression, it is possible that D activates opa. However, upon type II NB specific D knockdown, opa localization was unchanged ([Figure 4E](#fig4){ref-type="fig"}). Interestingly, D knockdown alone also did not prevent later temporal stages, Grh and Ey, to appear ([@bib8]), suggesting that other factor(s) are required to maintain temporal identities in INPs. Since Osa-depleted type II NB lineages fail to initiate temporal patterning ([@bib20]), we hypothesized that one of these unidentified factors could be a target of Osa that remains expressed in D-depleted INPs, such as opa. To test this hypothesis, we examined the epistatic genetic interactions between D and Opa. Double knock down of D and opa by type II NB-specific RNAi produced type II lineages containing fewer Dpn^+^/Ase^+^ INPs compared to controls ([Figure 4F--G](#fig4){ref-type="fig"}). This result suggests that even though D and opa are Osa targets, two of them alone cannot fully account for Osa tumor suppressor role ([Figure 4F--G](#fig4){ref-type="fig"}). Importantly, all known temporal identity markers on the remaining cells were absent, suggesting a complete loss of temporal identity in these INPs ([Figure 4F--G](#fig4){ref-type="fig"}). However, since these cells also lost their INP identity due to lack of Dpn and Ase, they exhibit a different phenotype than Osa knockdown. Therefore, our data suggest that opa is required for the repression of D, the activation of Grh, and thus the progression of temporal identities in INPs.

![Osa initiates D expression before initiating Opa.\
(**A**) Close-up images of fly brains endogenously expressing V5-tagged opa in INPs, stained for V5, Dpn and D. D^+^, V5^-^ cell is marked with arrows, lineages are outlined with yellow dashed line, scale bar 10 μm and 5 μm, (induced with ermGal4, marked with membrane bound GFP). (**B**) Close-up images of fly brains endogenously expressing V5-tagged opa in INPs, stained for V5, Dpn and Grh, lineages are outlined with yellow dashed line, scale bar 10 μm, (induced with ermGal4, marked with membrane bound GFP). (**C**) Quantifications of opa::V5-signal intensity measurements of D^+^ vs D^-^ INPs, n = 10, normalized to background intensity. Data represent mean ± SD, \*\*\*p\<=0.001, Student's t-test. (**D**) Quantifications of opa::V5-signal intensity measurements of Grh^+^ vs Grh^-^ INPs, n = 10, normalized to background intensity. Data represent mean ± SD, \*\*\*p\<=0.001, Student's t-test. (**E**) Close-up images of fly brains endogenously expressing V5-tagged opa and RNAi for D in type II lineages, stained for V5, Dpn and D, lineages are outlined with yellow dashed line, scale bar 10 μm, (induced with worGal4, aseGal80, marked with membrane bound GFP). (**F--G**) Close up images of control versus opa and D double knock-down brains in type II lineages, stained with Dpn, D and Grh (**C**), or for Dpn, Ey and Ase (**C**) antibodies, lineages are outlined with yellow dashed lines, scale bar 10 μm, (induced with Dcr2; UAS-StgRFP; VT17-Gal4, marked with nuclear RFP).\
10.7554/eLife.46566.026Figure 4---source data 1.Quantification of intensity measurements of opa::V5 signal in D^+^ versus D^-^ INPs in wild-type brains ([Figure 4C](#fig4){ref-type="fig"}).\
10.7554/eLife.46566.027Figure 4---source data 2.Quantification of intensity measurements of opa::V5 signal in Grh^+^ versus Grh^-^ INPs in wild-type brains ([Figure 4C](#fig4){ref-type="fig"}).](elife-46566-fig4){#fig4}

Opa is an expression level-dependent repressor of D {#s2-5}
---------------------------------------------------

If Opa suppresses D, one puzzling aspect of our data is the presence of double-positive D^+^/opa^+^ INPs ([Figure 4A](#fig4){ref-type="fig"}). To better understand this paradox, we overexpressed opa in type II NBs during a period before D is normally expressed. Overexpression of opa resulted in shorter lineages ([Figure 5---figure supplement 1A-B](#fig5s1){ref-type="fig"}), decreased total INP numbers ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}), and a loss of type II NBs (marked by Dpn or Mira) ([Figure 5---figure supplement 1A-B](#fig5s1){ref-type="fig"}). Co-expressing the apoptosis inhibitor p35 did not prevent NB loss or shortened lineages, suggesting that opa overexpression does not induce cell death, but causes premature differentiation instead ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). NBs and INPs overexpressing opa successfully segregated Mira and aPKC, excluding that asymmetric cell division was altered ([Figure 5---figure supplement 1D-E](#fig5s1){ref-type="fig"}, and [Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}). Overexpressing opa in type II NB lineages caused complete loss of D^+^ INPs, but the few remaining INPs could still activate Grh and Ey ([Figure 5A--C](#fig5){ref-type="fig"}), which is similar to D knockdown phenotype ([@bib8]).

![Opa overexpression results in the loss of D^+^INPs.\
(**A**) Close-up images of control and opa overexpressing brains in type II lineages, stained for Dpn, D and Grh antibodies, lineages are outlined with yellow dashed lines, scale bar 10 μm, (induced with worGal4, aseGal80, marked with membrane bound GFP). Overexpression of opa in type II lineages causes the loss of D^+^ INPs. (**B**) Close-up images of control and opa overexpressing brains in type II lineages, stained for Dpn, and Ey antibodies, lineages are outlined with yellow dashed lines, scale bar 10 μm, (induced with worGal4, aseGal80, marked with membrane bound GFP). (**C**) Quantification of D^+^, Grh^+^ and Ey^+^ INPs in control and opa overexpressing brains, n = 10, total INP numbers in control were normalized to 100%. Data represent mean ± SD, p\<=0.05, \*\*\*p\<=0.001, Student's t-test (D^+^ INPs control 12.18 ± 1.33 \[n = 10\], opa GOF 0.4 ± 0.6 \[n = 10\], p\<0.001; Grh^+^ INPs control 7.38 ± 1 \[n = 10\], opa GOF 5.12 ± 2.20 \[n = 10\], p\<0.05; Ey^+^ INPs control 13.5 ± 0.76 \[n = 10\], opa GOF 6 ± 3.5 \[n = 10\], p\<0.001). (**D**) Close-up images of control and opa overexpressing brains in INPs, stained for Dpn, and Ey, lineages are outlined with yellow dashed lines, scale bar 10 μm, (induced with ermGal4, marked with membrane bound GFP). (**E**) Close-up images of control and opa overexpressing brains in INPs, stained for Dpn, D and Grh, lineages are outlined with yellow dashed lines, scale bar 10 μm, (induced with ermGal4, marked with membrane bound GFP). (**F**) Quantification of D^+^, Grh^+^ and Ey^+^ INPs in control and opa overexpressing brains, n = 5, total INP numbers in control were normalized to 100%. Data represent mean ± SD, \*p\<=0.05, \*\*\*p\<0.001, Student's t-test (D^+^ INPs control 12.4 ± 1.01 \[n = 5\], opa GOF 4.83 ± 0.68 \[n = 5\], p\<0.0001; Grh^+^ INPs control 8.2 ± 1.16 \[n = 5\], opa GOF 10.33 ± 1.24 \[n = 5\], p\<0.05; Ey^+^ INPs control 13.4 ± 1.01 \[n = 5\], opa GOF 15.71 ± 1.9 \[n = 5\], p\<0.05).\
10.7554/eLife.46566.032Figure 5---source data 1.Quantification of number of INPs in three different temporal identities between control versus opa-overexpressed brains with type II-specific driver ([Figure 5C](#fig5){ref-type="fig"}).\
10.7554/eLife.46566.033Figure 5---source data 2.Quantification of number of INPs in three different temporal identities between control versus opa-overexpressed brains with INP-specific driver ([Figure 5F](#fig5){ref-type="fig"}).](elife-46566-fig5){#fig5}

To exclude that these could result from altered NB patterning, we next overexpressed opa in an INP-specific manner during a stage where D is normally expressed. Opa overexpression caused a decrease in D^+^ INPs ([Figure 5D--F](#fig5){ref-type="fig"}), and a concomitant increase in both Grh^+^ and Ey^+^ INP populations ([Figure 5D--F](#fig5){ref-type="fig"}). This result further indicates that Opa represses the early D^+^ temporal identity, but also activates later Grh^+^ temporal identity. We also overexpressed opa in DM1 lineages in an INP-specific manner, which resulted in a decrease in D^+^ INP numbers and an increase in Ey^+^ INPs ([Figure 5---figure supplement 2A and C](#fig5s2){ref-type="fig"}). However, ectopic Grh expression was undetectable ([Figure 5---figure supplement 2B](#fig5s2){ref-type="fig"}), suggesting opa mis-expression does not cause ectopic Grh expression. Collectively, these results show that opa-mediated repression of D depends on Opa expression levels.

Opa and ham together control the correct representation of each temporal identity {#s2-6}
---------------------------------------------------------------------------------

Having established an interaction between opa and D, we next wondered if opa and ham, two temporal switch genes, can recapitulate the Osa loss-of-function phenotype, a more upstream regulator of lineage progression in type II NBs. Osa knock-down causes INPs to revert back to the NB-state due to a failure to initiate temporal patterning, while single depletion of opa or ham leads to either an increase in D^+^ or Grh^+^ cells, respectively ([Figure 2](#fig2){ref-type="fig"}; [@bib20]). Co-expressing opa RNAi with ham shmiR in an INP-specific manner caused supernumerary Dpn^+^, Ase^+^ INPs ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). In addition, the number of D^+^/Dpn^+^ and Grh^+^/Dpn^+^ INPs were also increased, which is in contrast to single depletion of opa or ham ([Figure 6A--B](#fig6){ref-type="fig"}, [Figure 2](#fig2){ref-type="fig"}; [@bib20]). Thus, opa and ham loss-of-function phenotypes are additive. Importantly, despite inducing over-proliferation of mature INPs (Ase^+^/Dpn^+^), depleting both opa and ham in type II NBs could not recapitulate the Osa loss-of-function phenotype because imINPs could mature and express Ase, and therefore did not revert into ectopic NBs ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). This suggests that Osa regulates temporal patterning in two levels: initiation by D activation, and progression by opa and ham.

![Opa and hamlet are required for INP temporal patterning and correct lineage progression.\
(**A--B**) Overview images of brain lobes expressing RNAi against opa and ham in INPs and their close-up images (marked with yellow squares), stained for Dpn, D and Ey (**A**), or Dpn and Grh (**B**) antibodies, lineages and lobes are outlined with yellow dashed lines, scale bar 50 μm for brain lobes, 10 μm for zoomed images, (induced with ermGal4, marked with membrane bound GFP). (**C**) Model depicting the genetic interactions between temporal switch genes (opa and hamlet), and temporal identity genes (D, Grh, and Ey).](elife-46566-fig6){#fig6}

Discussion {#s3}
==========

Temporal patterning is a phenomenon where NSCs alter the fate of their progeny chronologically. Understanding how temporal patterning is regulated is crucial to understanding how the cellular complexity of the brain develops. Here, we present a novel, FACS-based approach that enabled us to isolate distinct temporal states of neural progenitors with very high purity from Drosophila larvae. This allowed us to study the transitions between different temporal identity states. We identified odd-paired (opa), a transcription factor that is required for INP temporal patterning. By studying the role of this factor in temporal patterning, we propose a novel model for the regulation of temporal patterning in *Drosophila* neural stem cells.

We establish two different roles of the SWI/SNF complex subunit, Osa, in regulating INP temporal patterning. Initially, Osa initiates temporal patterning by activating the transcription factor D. Subsequently, Osa regulates the progression of temporal patterning by activating opa and ham, which in turn downregulate D and Grh, respectively ([Figure 6C](#fig6){ref-type="fig"}). The concerted, but complementary action of opa and ham ensures temporal identity progression by promoting the transition between temporal stages. For instance, opa regulates the transition from D to Grh, while ham regulates the transition from Grh to Ey. We propose that opa achieves this by repressing D and activating grh, as indicated by the lack of temporal patterning in D and opa-depleted INPs ([Figure 4C--D](#fig4){ref-type="fig"}, [Figure 6C](#fig6){ref-type="fig"}). Loss of opa or ham causes INPs to lose their temporal identity and overproliferate. Moreover, we propose that D and opa activate Grh expression against the presence of ham, which represses Grh expression. As D and opa levels decrease as INPs age and become Grh positive, ham is capable of repressing Grh later on in temporal patterning ([Figure 6C](#fig6){ref-type="fig"}). This explains how opa and ham act only during specific stages even though they are expressed throughout the entire lineage.

An open question pertains to the fact that the double knock-down of opa and ham, as well as that of D and opa, failed to recapitulate the Osa phenotype. Even though opa and ham RNAi caused massive overproliferation in type II lineages, we could not detect any Dpn^+^ Ase^-^ ectopic NB-like cells (as occurs in Osa mutant clones, [@bib20]). We propose that this is caused by D expression which is still induced even upon opa/ham double knockdown, but not upon Osa knock-down where D expression fails to be initiated. Thus, the initiation of the first temporal identity state may block the reversion of INPs to a NB-state. In the future, it will be important to understand the exact mechanisms of how opa regulates temporal patterning.

We further demonstrate that Osa initiates D expression earlier than opa expression. Osa is a subunit of SWI/SNF chromatin remodeling complex, and it guides the complex to specific loci throughout the genome, such as the TSS of both D and opa. The differences in timing of D and opa expression may be explained by separate factors involved in their activation. Previous work suggests that the transcription factor earmuff may activate ([@bib35]; [@bib36]). However, it remains unknown which factor activates opa expression. One possibility is that the cell cycle activates opa, since its expression begins in mINPs, a dividing cell unlike imINPs, which are in cell cycle arrest.

We propose that balanced expression levels of D and opa regulates the timing of transitions between temporal identity states. Indeed, Osa initiates D and opa, the repressor of D, at slightly different times, which could allow a time window for D to be expressed, perform its function, then become repressed again by opa. Deregulating this pattern, for example by overexpressing opa in the earliest INP stage, results in a false start of temporal patterning and premature differentiation. This elegant set of genetic interactions resembles that of an incoherent feedforward loop (FFL) ([@bib37]; [@bib51]). In such a network, pathways have opposing roles. For instance, Osa promotes both the expression and repression of D. Similar examples can be observed in other organisms, such as in the galactose network of *E. coli*, where the transcriptional activator CRP activates galS and galE, while galS also represses galE ([@bib66]). In Drosophila SOP determination, miR-7, together with Atonal also forms an incoherent FFL ([@bib44]). Furthermore, mammals apply a similar mechanism in the c-Myc/E2F1 regulatory system ([@bib58]).

The vertebrate homologues of opa consist of the Zinc-finger protein of the cerebellum (ZIC) family, which are suggested to regulate the transcriptional activity of target genes, and to have a role in CNS development ([@bib19]; [@bib18]; [@bib22]; [@bib30]; [@bib31]). In mice, during embryonic cortical development, ZIC family proteins regulate the proliferation of meningeal cells, which are required for normal cortical development ([@bib32]). In addition, another member of the ZIC family, Zic1, is a Brn2 target, which itself controls the transition from early-to-mid neurogenesis in the mouse cortex ([@bib70]). Along with these lines, it has been shown that ZIC family is important in brain development in zebrafish ([@bib53]; [@bib65]). Furthermore, the role of ZIC has been implicated in variety of brain malformations and/or diseases ([@bib4]; [@bib12]; [@bib26]). These data provide mere glimpses into the roles of ZIC family proteins in neuronal fate decisions in mammals, and our study offers an important entry point to start understanding these remarkable proteins.

Our findings provide a novel regulatory network model controlling temporal patterning, which may occur in all metazoans, including humans. In contrast to existing cascade models, we instead show that temporal patterning is a highly coordinated ensemble that allows regulation on additional levels than was previously appreciated to ensure a perfectly balanced generation of different neuron/glial cell types. Together, our results demonstrate that *Drosophila* is a powerful system to dissect the genetic mechanisms underlying the temporal patterning of neural stem cells and how the disruption of such mechanisms impacts brain development and behavior.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                         Designation                                      Source or\                                                                                                                   Identifiers         Additional\
  (species) or\                                                                          reference                                                                                                                                        information
  resource                                                                                                                                                                                                                                
  ------------------------------------- ------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------- ------------------- -----------------------------------------------------------------------------------
  Gene (*Drosophila melanogaster*)      osa                                              NA                                                                                                                           FBgn0261885         

  Gene (*D. melanogaster*)              Dichaete                                         NA                                                                                                                           FBgn0000411         

  Gene (*D. melanogaster*)              Grainyhead                                       NA                                                                                                                           FBgn0259211         

  Gene (*D. melanogaster*)              Eyeless                                          NA                                                                                                                           FBgn0259211         

  Gene (*D. melanogaster*)              Hamlet                                           NA                                                                                                                           FBgn0045852         

  Gene (*D. melanogaster*)              Odd-paired                                       NA                                                                                                                           FBgn0003002         

  Genetic reagent (*D. melanogaster*)   UAS-CD8::GFP; *erm*GAL4                          PMID:[18621688](https://www.ncbi.nlm.nih.gov/pubmed/18621688) and [20152183](https://www.ncbi.nlm.nih.gov/pubmed/20152183)                       

  Genetic reagent (*D. melanogaster*)   UAS-CD8::tdTomato; *erm*GAL4                     PMID:[18621688](https://www.ncbi.nlm.nih.gov/pubmed/18621688) and [20152183](https://www.ncbi.nlm.nih.gov/pubmed/20152183)                       

  Genetic reagent (*D. melanogaster*)   UAS-*dcr2; wor*-GAL4, *ase*GAL80; UAS-CD8::GFP   PMID:[21549331](https://www.ncbi.nlm.nih.gov/pubmed/21549331)                                                                                    

  Genetic reagent (*D. melanogaster*)   *VT17*-GAL4                                      Vienna Drosophila RNAi Center                                                                                                212057, discarded   

  Genetic reagent (*D. melanogaster*)   UAS-*stinger*::RFP                               PMID:[11056799](https://www.ncbi.nlm.nih.gov/pubmed/11056799)                                                                                    

  Genetic reagent (*D. melanogaster*)   UAS-*opa*^RNAi^                                  Vienna Drosophila RNAi Center                                                                                                101531              

  Genetic reagent (*D. melanogaster*)   UAS-D^RNAi^                                      Vienna Drosophila RNAi Center                                                                                                49549 and 107194    

  Genetic reagent (*D. melanogaster*)   UAS-mcherry^shmiR^                               Bloomington Drosophila Stock Center                                                                                          35785               

  Genetic reagent (*D. melanogaster*)   UAS-osa^RNAi^                                    Vienna Drosophila RNAi Center                                                                                                7810                

  Genetic reagent (*D. melanogaster*)   UAS-ham^shmiR^                                   Bloomington Drosophila Stock Center                                                                                          32470               

  Genetic reagent (*D. melanogaster*)   UAS-osa^shmiR^                                   PMID:[2460726](https://www.ncbi.nlm.nih.gov/pubmed/2460726)                                                                                      

  Genetic reagent (*D. melanogaster*)   UAS-p35                                          PMID:[7925015](https://www.ncbi.nlm.nih.gov/pubmed/7925015)                                                                                      

  Genetic reagent (*D. melanogaster*)   UAS-opa                                          PMID:[17329368](https://www.ncbi.nlm.nih.gov/pubmed/17329368)                                                                                    

  Genetic reagent (*D. melanogaster*)   D::GFP                                           this paper                                                                                                                                       endogenously GFP-tagged D in C-terminus

  Genetic reagent (*D. melanogaster*)   Grh-GFP                                          Bloomington Drosophila Stock Center                                                                                          42272               

  Genetic reagent (*D. melanogaster*)   Ey-GFP                                           Bloomington Drosophila Stock Center                                                                                          42271               

  Genetic reagent (*D. melanogaster*)   opa::V5                                          this paper                                                                                                                                       endogenously V5-tagged opa in C-terminus

  Genetic reagent (*D. melanogaster*)   FRT82B, *opa*^7^                                 PMID:[17329368](https://www.ncbi.nlm.nih.gov/pubmed/17329368)                                                                                    

  Genetic reagent (*D. melanogaster*)   *elav*Gal4 (C155)                                PMID:[10197526](https://www.ncbi.nlm.nih.gov/pubmed/10197526)                                                                                    

  Genetic reagent (*D. melanogaster*)   actCas9                                          Bloomington Drosophila Stock Center                                                                                          54590               

  Genetic reagent (*D. melanogaster*)   hsCre                                            Bloomington Drosophila Stock Center                                                                                          851                 

  Antibody                              anti-Deadpan (guinea pig, polyclonal)            PMID:[2460726](https://www.ncbi.nlm.nih.gov/pubmed/2460726)                                                                                      (1:1000)

  Antibody                              anti-Asense (rat, polyclonal)                    PMID:[2460726](https://www.ncbi.nlm.nih.gov/pubmed/2460726)                                                                                      (1:500)

  Antibody                              anti-Miranda (guinea pig, polyclonal)            PMID:[2460726](https://www.ncbi.nlm.nih.gov/pubmed/2460726)                                                                                      (1:500)

  Antibody                              anti-Grainyhead (rat, polyclonal)                PMID:[19945380](https://www.ncbi.nlm.nih.gov/pubmed/19945380)                                                                                    (1:1000)

  Antibody                              anti-Dichaete (rabbit, polyclonal)               gift from Steve Russell                                                                                                                          (1:1000)

  Antibody                              anti-Eyeless (mouse, monoclonal)                 Developmental Studies Hybridoma Bank                                                                                         anti-eyeless        (1:50), RRID:[AB_2253542](https://scicrunch.org/resolver/AB_2253542)

  Antibody                              anti-Toy (guinea pig, polyclonal)                gift from Uwe Walldorf                                                                                                                           (1:500)

  Antibody                              anti-Bsh (guinea pig, polyclonal)                gift from Makoto Sato, PMID:[21303851](https://www.ncbi.nlm.nih.gov/pubmed/21303851)                                                             (1:500), RRID:[AB_2567934](https://scicrunch.org/resolver/AB_2567934)

  Antibody                              anti-V5 (mouse, monoclonal)                      Sigma Aldrich                                                                                                                V8012               (1:500 IF, 1:1000 WB), RRID:[AB_261888](https://scicrunch.org/resolver/AB_261888)

  Antibody                              anti-Bruchpilot nc82 (mouse, monoclonal)         Developmental Studies Hybridoma Bank                                                                                         nc82                (1:10), RRID:[AB_2314866](https://scicrunch.org/resolver/AB_2314866)

  Antibody                              anti-V5 IgG2a (mouse, monoclonal)                Thermo Fisher Scientific                                                                                                     R960-25             (1:500), RRID:[AB_2556564](https://scicrunch.org/resolver/AB_2556564)

  Antibody                              anti-V5 (rabbit, polyclonal)                     Abcam                                                                                                                        ab9116              (1:500), RRID:[AB_307024](https://scicrunch.org/resolver/AB_307024)

  Antibody                              anti-Prospero (mouse, monoclonal)                Developmental Studies Hybridoma Bank                                                                                         MR1A                (1:20), RRID:[AB_528440](https://scicrunch.org/resolver/AB_528440)

  Antibody                              anti-pH3(Ser10) (mouse, monoclonal)              Cell Signaling Technologies                                                                                                  9706S               (1:1000), RRID:[AB_331748](https://scicrunch.org/resolver/AB_331748)

  Antibody                              anti-aPKC (rabbit, polyclonal)                   Santa Cruz Biotechnologies                                                                                                   sc-216              (1:500), RRID:[AB_2300359](https://scicrunch.org/resolver/AB_2300359)

  Antibody                              anti-alpha tubulin\                              Sigma Aldrich                                                                                                                T6199               (1:10000), RRID:[AB_477583](https://scicrunch.org/resolver/AB_477583)
                                        (mouse, monoclonal)                                                                                                                                                                               

  Antibody                              Alexa 405, 568, 647                              Invitrogen                                                                                                                   Alexa Fluor dyes    (1:500)

  Antibody                              IRDye 700, 800                                   LI-COR                                                                                                                       IRDye               (1:15000)

  Software, algorithm                   Prism 7                                          GraphPad Software                                                                                                                                

  Software, algorithm                   BWA                                              PMID:[19451168](https://www.ncbi.nlm.nih.gov/pubmed/19451168)                                                                                    RRID:[SCR_010910](https://scicrunch.org/resolver/SCR_010910)

  Software, algorithm                   TopHat                                           PMID:[19289445](https://www.ncbi.nlm.nih.gov/pubmed/19289445)                                                                                    RRID:[SCR_013035](https://scicrunch.org/resolver/SCR_013035)

  Software, algorithm                   HTSeq                                            PMID:[25260700](https://www.ncbi.nlm.nih.gov/pubmed/25260700)                                                                                    RRID:[SCR_005514](https://scicrunch.org/resolver/SCR_005514)

  Software, algorithm                   DESeq2 (v1.12.4)                                 PMID:[25516281](https://www.ncbi.nlm.nih.gov/pubmed/25516281)                                                                                    RRID:[SCR_016533](https://scicrunch.org/resolver/SCR_016533)

  Software, algorithm                   bedtools (v2.26.0)                               PMID:[20110278](https://www.ncbi.nlm.nih.gov/pubmed/20110278)                                                                                    RRID:[SCR_006646](https://scicrunch.org/resolver/SCR_006646)

  Commercial assay                      TRIzol LS                                        Ambion                                                                                                                       10296010            

  Commercial assay                      Agencourt AMPure XP beads                        Beckman Coulter                                                                                                              A63880              

  Commercial assay                      Nextera DNA Library Prep Kit                     Illumina                                                                                                                     FC-121--1031        

  Recombinant DNA reagent               pU6-Bbsl-chiRNA                                  PMID:[23709638](https://www.ncbi.nlm.nih.gov/pubmed/23709638)                                                                                    

  Other                                 Rinaldini solution                               PMID:[22884370](https://www.ncbi.nlm.nih.gov/pubmed/22884370)                                                                                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fly strains, RNAi, and clonal analysis {#s4-1}
--------------------------------------

The following *Drosophila* stocks were used: UAS-*opa*^RNAi^ (VDRC, TID: 101531), UAS-mcherry^shmiR^ (BL35785), UAS-D^RNAi^ (VDRC, TID: 49549, 107194), UAS-osa^RNAi^ (VDRC, TID: 7810), UAS-ham^shmiR^ (BL32470), UAS-osa^shmiR^ ([@bib20]), UAS-p35, UAS-opa ([@bib42]), PBac{grh-GFP.FPTB}VK00033 (BL42272), PBac{EyGFP.FPTB}VK00033 (BL42271) ([@bib67]), D::GFP (generated in this study), opa::V5 (generated in this study). GAL4 driver lines used: UAS-cd8::tdTomato; *erm*Gal4, UAS-cd8::GFP; *erm*Gal4 ([@bib60]; [@bib74]), UAS-*dcr2; wor*Gal4, *ase*Gal80; UAS-cd8::GFP ([@bib57]), UAS-*dcr2*; UAS-cd8::GFP; VT17-Gal4 (VDRC, TID: 212057, discarded). Mutant fly strains used for clonal analysis were FRT82B, *opa*^7^ ([@bib42]). Clones were generated by Flippase (FLP)/FLP recombination target (FRT)-mediated mitotic recombination, using the *elav*Gal4 (C155) ([@bib43]). Larvae were heat shocked for 90 min at 37°C and dissected as third-instar wandering larvae (120 hr). RNAi crosses were set up and reared at 29°C, and five days later, third-instar wandering larvae were dissected. *w^118^* was used as control for comparison with RNAi lines, whereas UAS-mcherry^shmiR^ was used as control for comparison with shmiR lines, and experiments involving UAS-transgenes.

Generation of opa::V5 and D::GFP flies {#s4-2}
--------------------------------------

For both genes, the guides were cloned as overlapping oligos into linearized pU6-BbsI-chiRNA (Addgene 45946, [@bib23]) and injected at 100 ng/μl into actCas9 flies (BL 54590, [@bib61]). Donors (either oligos or plasmid) were co-injected at 250 ng/μl. For opa, donors were Ultramer Oligos from IDT with around 60nt homology arms on either side. For D, homology arms were 800 bp and 900 bp long. Donor plasmid contained GFP, V5, 3xFlag, and dsRed. They were screened for dsRed eyes and then, the selection cassette was removed with hsCre (BL 851). *opa* gRNA GATGCATCCCGGCGCAGCGA *opa* donor GAACCCGCTGAACCATTTCGGACACCATCACCACCACCACCACCTGATGCATCCCGGCGCgGCaACcGCGTATggtaagcctatacctaaccctcttcttggTCTAGAtagcacgTGAGAGTGGGAGAACTGGTGGCCCGAGGAGGCGCCACCGCCGGCCGCCCAACCGA

*D* gRNA GTGCTCTATTAGAGTGGAGT

Negative geotaxis assay {#s4-3}
-----------------------

Negative geotaxis assay was used as described before ([@bib1]), where the percentage of flies passing the 8.5 cm mark in 10 s was assessed. For each genotype and gender, 10 two-day old adult flies in 10 biological replicates were measured and for each replicate, 10 measurements were performed with 1 min rest period in between.

Immunohistochemistry and antibodies {#s4-4}
-----------------------------------

Larval or adult brains were dissected in 1X PBS, and then fixed for 20 min at room temperature (RT) in 5% paraformaldehyde in PBS and washed once with 0.1% TritonX in PBS (PBST). The brains were incubated for 1 hr at RT with blocking solution (5% normal goat serum or 1% BSA in PBST). Blocking was followed by overnight incubation at 4°C with primary antibodies in blocking solution. Then, the brains were washed three times with PBST, and incubated for 1 hr at RT with secondary antibodies (1:500, goat Alexa Fluor, Invitrogen) in blocking solution. After secondary antibody, brains were washed three times with PBST, and mounted in Vectashield Antifade Mounting Medium (Vector Labs).

Antibodies used in this study were: guinea pig anti-Deadpan (1:1000, [@bib20]), rat anti-Asense (1:500, [@bib20]), guinea pig anti-Miranda (1:500, [@bib20]), rat anti-Grh (1:1,000; [@bib5]); rabbit anti-D (1:1,000; gift from Steve Russell); mouse anti-Ey (1:10; DSHB); guinea pig anti-Toy (gift from Uwe Walldorf), guinea pig anti-Bsh (gift from Makoto Sato), mouse anti-Bruchpilot nc82 (1:10, DSHB), mouse anti-V5 (1:500, Sigma Aldrich, V8012), mouse antiV5 IgG2a (Thermo Fisher Scientific, R960-25, used in [Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}), rabbit anti-V5 (Abcam, ab9116, used in [Figure 4---figure supplement 3A](#fig4s3){ref-type="fig"}), mouse anti-Pros (1:100, Developmental Studies Hybridoma Bank), mouse anti-pH3(Ser10) (1:500, Cell Signaling Technologies, 9701S), rabbit anti-aPKC (1:500, Santa Cruz Biotechnology, sc-216). Throughout the paper, for every quantification, dorsomedial 2 and 3 type II NB lineages (DM2 and 3) were considered, if not stated otherwise.

In vitro immunofluorescence {#s4-5}
---------------------------

FACS-sorted cells from \~300 larval brains (UAS-cd8::tdTomato, *erm*Gal4) or their unsorted control matches were plated on cover glass (Labtek II Chambered Coverglass, 8-well, 155409, Thermo Fisher Scientific) into Schneider's medium ([@bib28]). The dishes were placed onto ice and cells were incubated for 1 hr to settle down. Cells were then fixed with 5% PFA in PBS at RT and washed three times with 0.1% PBST. After washes, cells were incubated for 1 hr at RT with blocking solution (5% normal goat serum in 0.1% PBST). The cells were then incubated overnight at 4°C with primary antibodies in blocking solution, which was followed by three washes with 0.1% PBST, and secondary antibody (1:500, goat Alexa Fluor, Invitrogen) incubation for 1 hr at RT. Cells were again washed three times with 0.1% PBST, and then mounted in in Vectashield Antifade Mounting Medium with Dapi (Vector Labs).

Microscopy {#s4-6}
----------

Confocal images were acquired with Zeiss LSM 780 confocal microscopes.

Western blot {#s4-7}
------------

Embryos were collected and dechorionated, then boiled in 2x Laemmli buffer and loaded on 4--12% gradient Bis-Tris gels (NuPAGE, Invitrogen). After SDS-PAGE according to Invitrogen's protocol, proteins were transferred to a Nitrocellulose membrane (0.22 µm, Odyssey LI-COR) for 2 hr at 100V, blocked with 5% milk powder in blocking solution (PBS with 0.2% Tween) for 1 hr, overnight incubation with primary antibody in blocking solution at 4°C, 3x washed with washing solution (PBS with 0.1% Tween) and followed by 1 hr incubation with secondary antibody (1:15000, goat IRDye, LI-COR)in blocking solution. After three washes with washing solution, the membranes were air-dried, and fluorescent signal were detected with Odyssey CLx imaging system (Odyssey CLx LI-COR). Antibodies used were: mouse anti-V5 (1:1000, Sigma Aldrich, V8012), anti-alpha tubulin (1:10000, Sigma Aldrich, T6199).

Intensity measurements {#s4-8}
----------------------

For intensity measurements of opa-V5 signal, cells expressing Dpn and temporal identity markers (D, Grh or Ey) were circled with selection tools. Raw integrity density (sum of gray values of all selected pixels) was measured using FIJI. In each image, five temporal identity positive INP and five temporal identity negative INP were measured for raw integrity density along with three background circles with no opa-V5 signal, (eg. D^+^ vs D^-^ INPs). Then, corrected total cell fluorescent (CTCF) were calculated with 'Integrated density -- (Area of selected cells X Mean fluorescence of background readings)' ([@bib54]). Then, the mean of temporal identity positive versus negative cells were calculated and the values were normalized to means of background for each brain.

Statistics {#s4-9}
----------

Statistical analyses were performed with GraphPad Prism 7. Unpaired two-tailed Student's *t*-test was used to assess statistical significance between two genotypes. Experiments were not randomized, and investigator was not blinded. Sample sizes for experiments were estimated on previous experience with similar setup which showed significance, thus, no statistical method was used to determine sample size.

Cell dissociation and FACS {#s4-10}
--------------------------

Cell dissociation and FACS were performed as previously described with minor changes ([@bib11]; [@bib25]). UAS-cd8::tdTomato; *erm*Gal4 driver line was used to induce expression of membrane bound tdTomato in INPs. In addition to the driver lines, temporal identity factors were tagged with GFP. Flies expressing both fluorophores were dissected at L3 stage, and then dissociated into single cell suspension. Decreasing levels of tdTomato were observed in differentiated cells due to lack of driver line expression. Thus, biggest cells with highest tdTomato expression and highest GFP expression were sorted.

For RNA isolation, cells were sorted directly in TRIzol LS (10296010, Invitrogen), while for cell staining, they were sorted on coated glass-bottomed dishes and stained as previously described ([@bib11]).

RNA isolation, cDNA synthesis and qPCR {#s4-11}
--------------------------------------

RNA was isolated using TRIzol LS reagent (10296010, Invitrogen) from FACS sorted cells. Then RNA samples were used as template for first-strand cDNA synthesis with random hexamer primers (SuperScriptIII, Invitrogen). qPCR was done using Bio-Rad IQ SYBR Greeen Supermix on a Bio-Rad CFX96 cycler. Expression of each gene was normalized to Act5c, and relative levels were calculated using the 2^-ΔΔCT^ method ([@bib47]). Primer used were:

*act5c* AGTGGTGGAAGTTTGGAGTG, GATAATGATGATGGTGTGCAGG

*D* ATGGGTCAACAGAAGTTGGGAG, GTATGGCGGTAGTTGATGGAATG

*grh* TCCCCTGCTTATGCTATGACCT, TACGGCTAGAGTTCGTGCAGA

*ey* TCGTCCGCTAACACCATGA, TGCTCAAATCGCCAGTCTGT

*ham* ATAGATCCTTTGGCCAGCAGAC, AGTACTCCTCCCTTTCGGCAAT

*opa* CTGAACCATTTCGGACACCATC, CCAGTTCTCCCACTCTCAATAC

RNA sequencing -- DigiTAG {#s4-12}
-------------------------

For each experiment 6000--7000 FACS-sorted D^+^, Grh^+^ or Ey^+^ INPs were isolated by TRIzol purification. Three replicates from each temporal state were analyzed. RNA samples were reverse transcribe into first-strand cDNA using SuperScriptIII Reverse Transcriptase (Invitrogen) with oligo-(dT)2- primers. Then the second-strand cDNA were generated. It was followed by library preparation with Nextera DNA Library Preparation Kit (Illumina) as previously described ([@bib41]; [@bib75]). Libraries were purified with Agencourt AMPure XP beads. Purified libraries were then subjected to 50 base pair Illumina single-end sequencing on a Hiseq2000 platform.

Transcriptome data analysis {#s4-13}
---------------------------

### Alignment {#s4-13-1}

Unstranded reads were screened for ribosomal RNA by aligning with BWA (v0.7.12; [@bib45]) against known rRNA sequences (RefSeq). The rRNA subtracted reads were aligned with TopHat (v2.1.1; [@bib38]) against the Drosophila genome (FlyBase r6.12). Introns between 20 and 150,000 bp are allowed, which is based on FlyBase statistics. Microexon-search was enabled. Additionally, a gene model was provided as GTF (FlyBase r6.12).

### Deduplication {#s4-13-2}

Reads arising from duplication events are marked as such in the alignment (SAM/BAM files) as follows. The different tags are counted at each genomic position. Thereafter, the diversity of tags at each position is examined. First, tags are sorted descending by their count. If several tags have the same occurrence, they are further sorted alphanumerically. Reads sharing the same tag are sorted by the mean PHRED quality. Again, if several reads have the same quality, they are further sorted alphanumerically. Now the tags are cycled through by their counts. Within one tag, the read with the highest mean PHRED quality is the unique cor- rect read and all subsequent reads with the same tag are marked as duplicates. Furthermore, all reads that have tags with one mis- match difference compared the pool of valid read tags are also marked as duplicates.

### Summarization {#s4-13-3}

Small nuclear RNA, rRNA, tRNA, small nucleolar RNA, and pseudogenes are masked from the GTF (FlyBase r6.12) with subtractBed from bedtools (v2.26.0; [@bib62]). The aligned reads were counted with HTSeq (v0.6.1; intersec- tion-nonempty), and genes were subjected to differential expres- sion analysis with DESeq2 (v1.12.4; [@bib49]).

Hierarchical clustering analysis {#s4-14}
--------------------------------

Genes are filtered by the indicated log2fc and an adjusted P value \< 0.05 in at least one pairwise comparison. In addition, a minimal expression of 10 RPM in at least one condition was required. The tree cut into four clusters (different cluster numbers were tested; [@bib40], 202AD). GO analysis was performed with FlyMine ([@bib50]), Holm-Bonferroni correction with max p-value 0.05 was used. Biological process and molecular function were the ontologies.

Accession numbers {#s4-15}
-----------------

The Gene Expression Omnibus accession number for the RNA-sequencing data reported in this paper is GSE127516.

GO-term analysis {#s4-16}
----------------

Gene Ontology (GO) enrichment analysis were performed on www.flymine.org/with Holm-Bonferroni correction with max p-value 0.05. Biological process and molecular function were the ontologies.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Transcription factor Odd-paired regulates temporal identity in neural progenitors via an incoherent feed-forward loop\" for consideration by *eLife*. Your article has been reviewed by three reviewers and the evaluation has been overseen by K VijayRaghavan as the Senior and Reviewing Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Hongyan Wang (Reviewer \#1); Sonia Sen (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. This a very nice study with valuable conclusions. Congratulations.

Summary:

In the *Drosophila* brain, Type II neuroblasts (NBs) generate transit-amplifying lineages (INPs) that divide like Type I NBs to expand the neural population. Like the NBs, INPs too experience temporal patterning allowing them to generate different progeny over time. The temporal cascade in INPs consists of D\>Grh\>Ey and earlier work from this lab had uncovered the mechanism by which the cascade is initiated in INPs (via Osa activating D), and the mechanism by which the Grh\>Ey temporal switch occurred (via Ham repressing Grh). However, much remains unknown in INP temporal patterning.

In this work, Abdusselamoglu et al., take a transcriptomic approach to this problem. They use FACS sorting to isolate the three temporally distinct INP populations followed by RNA-seq analysis to identify genes that are differentially expressed at these stages. To identify factors that ensure proper temporal switching in the INPs, the authors focus on Opa, which displays an RNA expression profile complementary to Ham. Using genetic manipulations and immunohistochemistry, they show that Opa is activated by Osa, and is responsible for repressing D (the first temporal factor in the INP). They also show neural fate specification effects that are consistent with this temporal progression.

Overall the data are of high quality, well documented and clearly presented. To my knowledge, this is the first time INP temporal patterning has been revisited since their first descriptions in 2013 and 2014, and so this manuscript advances our understanding in this field. This is particularly true due to the nature of the approach taken and the tools generated in the process.

Before we highlight the major concerns which can be speedily addressed, here are some specific points, appreciating the study, that a reviewer raised, which could be of value to the authors.

Some general comments which may be useful:

The differentially regulated genes in the temporal windows belong to different GO terms, which are difficult to make sense of, except for the presence of glial markers in the later Ey temporal window. This is of reduced importance.

However, the authors then focus on genes that regulate the transitions from one window to the next. The find that opa is a good candidate as a \'target\' of Osa, a component of the SWI/SNF complex. Opa has an expression pattern that is anti-correlated with Hamlet. Interestingly, opa mutants appears to stop the progression of the temporal clock at D, and later windows do not open. The authors conclude that opa inhibits D and acts to promote the transition from D to Grh and correspondingly, leads to the accumulation of Bsh early neurons and the loss of late Eya neurons. But then how is opa controlled to inhibit D if both are osa targets?

The most interesting part of the paper deals with the answer to this question and presents a model that osa regulates both opa and Dichaete, but with very different kinetics: they propose that opa represses D, and thus allow the progression of the temporal cascade and the activation of Grh. This is where the authors introduce the notion of an incoherent feed-forward loop in which osa activates both opa and D, but then opa represses D, but only late as it is turned on later than D. This is an excellent motif to allow temporal progression (or circling).

The paper is very solid and makes robust conclusions, and the model that the timing of expression controls the efficiency of their incoherent FFL is well supported and consistent with the data.

Therefore, the work adds one important detail to the concept that temporal windows progress through time. They show that a circuit motif allows the efficient progression of the cascade. Even if opa is not a temporal factor, it plays an important role in the transitions. We believe that this is an important result.

A concern though is the role of osa, which controls everything while it is a chromatin complex that is recruited by transcription factors: what these TFs are, remains a mystery although their identification would be a major breakthrough.

Essential revisions:

1\) When expressing D-GFP, Ey-GFP and Grh-GFP for FACS sorting, are they expressed under their endogenous level to avoid overexpression effect? The D-GFP was described in the methods and appeared to be based on CRISPR/Cas9- mediated gene editing. If this is true, please indicate it clearly. There is no description or citation for the generation of Ey-GFP and Grh-GFP.

2\) In FACS-purified GrH^+^ INPs (Figure 2F), the expression Ey is also high. What is the reason for this contamination? Does it mean that many INPs have co-expression of Grh and Ey at the same time?

3\) The reason for choosing to focus on Opa is unclear. The expression of Ham in D+, GrH^+^ and Ey^+^ INPs are similar, only fluctuating slightly. Therefore, the expression pattern of Ham doesn\'t seem to be a good example of dynamic expression in INPs. Can the authors clearly indicate how many genes have dynamic expression patterns in INPs and what criteria, i.e. based on fold changes, is applied to rank and select Opa? Currently, it appeared to be hand-picked.

4\) Is asymmetric division of INPs impaired and resulting in the change of INPs numbers upon loss-of-opa or opa overexpression?

5\) We appreciate the excellent quality of the FACS sorting of the three temporally distinct INP populations and are very impressed with how cleanly the authors were able to isolate the 3 populations, and how well they have documented it! This makes the RNA-seq data particularly invaluable to the field.

6\) With respect to Opa and its place in the temporal transitions, we are largely in agreement with the authors and their interpretations. They propose a model where Opa represses D and suggest that Opa also activates Grh. However, in their subsequent interpretations they seem to consider Opa\'s repression of D as its main mechanism of action in temporal progression. Would not Opa\'s activation of Grh, leading indirectly to repression of D, tie in all the data from this and the Byaraktar and Eroglu papers better? It would explain why D^+^, Opa^+^ double positive INPs are seen at all, why D-/- INPs can still progress through the temporal cascade, and why overexpressing Opa resulted in loss of D^+^ INPs and increase in GrH^+^, Ey^+^ INPs (incomplete expression of Grh in UAS-Opa shown in Figure 5 might be due to presence of Ham). Furthermore, it would not call upon differential levels of expression of Opa (which the authors have not shown at the protein level), as timing of expression/inhibition of these genes as the INP divides might account for the temporal transitions.

7\) If the authors agree with this, have they looked at the DM1 lineage, which is known to not express Grh? Is Opa expressed in this lineage? If not, does misexpression of Opa there result in Grh activation and D repression? The authors have analysed this in DM2 and DM3 -- the same brains could be analysed for DM1.

8\) The authors must have verified the Opa:V5 tool before using it. Could they please describe this?

9\) The authors show that D comes up in INPs before Opa does. However, this is not very clear from the images. Could the authors maybe show magnified insets of these types INPs with the two reporters co-localised? Am I right in understanding that apart from this one difference, Opa is co-localised with every other temporal factor in the INPs? Related to this, the authors find that Opa RNA levels are high early and late in the lineage, and dip in the middle. Do the protein levels reflect these dynamics? Their discussion seems to suggest it does.

10.7554/eLife.46566.042

Author response

> Essential revisions:
>
> 1\) When expressing D-GFP, Ey-GFP and Grh-GFP for FACS sorting, are they expressed under their endogenous level to avoid overexpression effect? The D-GFP was described in the methods and appeared to be based on CRISPR/Cas9- mediated gene editing. If this is true, please indicate it clearly. There is no description or citation for the generation of Ey-GFP and Grh-GFP.

We apologize for this oversight and have now 1) included the reference for Grh and Ey-GFP flies (commercially available stocks through Bloomington *Drosophila* Stock Center) and 2) clarified our description of the D-GFP strain (subsection "Transcriptome analysis of distinct INP temporal states". Grh-GFP and Ey-GFP strains have been generated through the insertion of C-terminally-tagged BAC-clones (subsection "Transcriptome analysis of distinct INP temporal states"). To exclude potential influence of Grh or Ey extra copies on temporal patterning, we quantified the numbers of each three different INP subpopulations and found no significant difference compared to wild-type. These new data are now included in Figure1---figure supplement1A.

> 2\) In FACS-purified GrH^+^ INPs (Figure 2F), the expression Ey is also high. What is the reason for this contamination? Does it mean that many INPs have co-expression of Grh and Ey at the same time?

We agree with the reviewer that the Ey mRNA levels in GrH^+^ INPs are high at the mRNA level. However, our staining showed that the amount of Ey protein as monitored by IF in GrH^+^ INPs was very low (Figure 1D and Figure 1F). We are confident that both our transcriptome data and IF are correct and that Ey mRNA level in this case does not reflect its protein level. This could further suggest a post-transcriptional regulation of Ey during Grh-to-Ey transition. We have now included this important point in subsection "Transcriptome analysis of distinct INP temporal states".

> 3\) The reason for choosing to focus on Opa is unclear. The expression of Ham in D^+^, GrH^+^ and Ey^+^ INPs are similar, only fluctuating slightly. Therefore, the expression pattern of Ham doesn\'t seem to be a good example of dynamic expression in INPs. Can the authors clearly indicate how many genes have dynamic expression patterns in INPs and what criteria, i.e. based on fold changes, is applied to rank and select Opa? Currently, it appeared to be hand-picked.

We have followed reviewer's suggestions and now included a list of dynamic genes with the selection criteria in subsection" Transcriptome analysis of distinct INP temporal states". Opa was chosen as it scored the highest fifth among the dynamically expressed genes (49 genes in total).

> 4\) Is asymmetric division of INPs impaired and resulting in the change of INPs numbers upon loss-of-opa or opa overexpression?

To address this, we performed pH3, Miranda and aPKC staining in control, opa knock-down and opa overexpression brains. We have found in all cases, Miranda and aPKC localized to opposite poles as expected in asymmetric cell division, indicating that asymmetric cell division is not affected (Figure 2---figure supplement 2E and Figure 5---figure supplement 1D-E). We rather think that these observed differences in total INPs numbers are due to the known connections between temporal patterning and cell cycle (Ey was shown to be required to end INP proliferation). Upon opa loss, we believe that the prolonged early temporal patterning allows more cell divisions for each INP, resulting in an increased cumulative number of INPs. In the case of opa over-expression, where D is skipped and Ey comes earlier, we would expect the opposite phenomenon to happen.

> 5\) We appreciate the excellent quality of the FACS sorting of the three temporally distinct INP populations and are very impressed with how cleanly the authors were able to isolate the 3 populations, and how well they have documented it! This makes the RNA-seq data particularly invaluable to the field.

We thank the reviewer for this comment.

> 6\) With respect to Opa and its place in the temporal transitions, we are largely in agreement with the authors and their interpretations. They propose a model where Opa represses D and suggest that Opa also activates Grh. However, in their subsequent interpretations they seem to consider Opa\'s repression of D as its main mechanism of action in temporal progression. Would not Opa\'s activation of Grh, leading indirectly to repression of D, tie in all the data from this and the Byaraktar and Eroglu papers better? It would explain why D^+^, Opa^+^ double positive INPs are seen at all, why D-/- INPs can still progress through the temporal cascade, and why overexpressing Opa resulted in loss of D^+^ INPs and increase in GrH^+^, Ey^+^ INPs (incomplete expression of Grh in UAS-Opa shown in Figure 5 might be due to presence of Ham). Furthermore, it would not call upon differential levels of expression of Opa (which the authors have not shown at the protein level), as timing of expression/inhibition of these genes as the INP divides might account for the temporal transitions.

We thank the reviewer for this great suggestion. We indeed cannot completely exclude that Opa's main role would be to activate Grh, leading to an indirect D repression. However, Bayraktar et al. showed that Grh LOF led to prolonged D expression, which was eventually repressed, while Grh GOF didn't affect the number of D^+^ or Ey^+^ INPs. These data suggest that Grh is not sufficient to repress D and would argue against Opa acting solely on Grh activation.

> 7\) If the authors agree with this, have they looked at the DM1 lineage, which is known to not express Grh? Is Opa expressed in this lineage? If not, does misexpression of Opa there result in Grh activation and D repression? The authors have analysed this in DM2 and DM3 -- the same brains could be analysed for DM1.

We thank the reviewer for this great suggestion. Opa is expressed in all type II lineages, including DM1 (Figure 4---figure supplement 1E). We analyzed opa's role in DM1 lineages which don't express Grh naturally, with both loss and gain of function experiments. Our results showed that opa is required in DM1 lineages in order to repress D expression (Figure 2---figure supplement 1A-C). Furthermore, in the case of opa overexpression, D^+^ INP numbers were significantly decreased (Figure 5---figure supplement 2A-C). Nonetheless, opa overexpression didn't cause ectopic Grh expression in DM1 lineages (Figure 5---figure supplement 2B). These data altogether further support that opa's main function is to repress D expression.

> 8\) The authors must have verified the Opa:V5 tool before using it. Could they please describe this?

We apologize for this oversight. We did verified the opa::V5 transgenics by Western blot (Figure 4 ---figure supplement 1A) and by IF upon knock-down looking at V5 expression (Figure 4---figure supplement 1F-G).

*9) The authors show that D comes up in INPs before Opa does. However, this is not very clear from the images. Could the authors maybe show magnified insets of these types INPs with the two reporters co-localised? Am I right in understanding that apart from this one difference, Opa is co-localised with every other temporal factor in the INPs? Related to this, the authors find that Opa RNA levels are high early and late in the lineage, and dip in the middle. Do the protein levels reflect these dynamics? Their discussion seems to suggest it does.*

We have now included the close-up images of D and opa localization (Figure 4A). We further included opaV5 staining together with Grh and Ey (Figure 4B and Figure 4---figure supplement 3A). To analyze the differential expression level of opa in INPs, we measured the intensity of opaV5 levels in these three INP subpopulations (Figure 4A-D and Figure 4---figure supplement 3A-B). Indeed, we found that D^+^ INPs have higher opaV5 levels than D^-^ INPs, while GrH^+^ INPs have lower levels than Grh^-^ INPs. Finally, Ey^+^ INPs have similar levels of opaV5 levels as Ey^-^ INPs, which is expected as Ey^-^ INPs contain both opa^high^ D^+^ and opa^low^ GrH^+^ INPs.

[^1]: Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.
